Skip to main content
Erschienen in: Abdominal Radiology 9/2016

02.05.2016

Histogram analysis of noncancerous liver parenchyma on gadoxetic acid-enhanced MRI: predictive value for liver function and pathology

verfasst von: Yoshiki Asayama, Akihiro Nishie, Kousei Ishigami, Yasuhiro Ushijima, Yukihisa Takayama, Daisuke Okamoto, Nobuhiro Fujita, Tomoharu Yoshizumi, Tomoyuki Hida, Hiroshi Honda

Erschienen in: Abdominal Radiology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To clarify whether the heterogeneity of hepatic parenchyma in the hepatobiliary phase on gadoxetic acid-magnetic resonance (MR) imaging is correlated with liver damage.

Materials and methods

We retrospectively examined the cases of 98 patients with or without chronic liver disease who underwent gadoxetic acid-enhanced 3T MR imaging before a hepatectomy between December 2010 and October 2014. For the evaluation of the heterogeneity of the signal intensity in the hepatobiliary phase, we placed the region of interest on the hepatic parenchyma, and the skewness and kurtosis were calculated using ImageJ software. A discriminant analysis was performed to examine the routine preoperative laboratory test results including indocyanine green retention at 15 min (ICG-R15), necro-inflammation grade, and liver fibrosis stage according to the METAVIR system: A0/1 (n = 69) and A2 (n = 29); F0/1 (n = 47), F2/3 (n = 31), and F4 (n = 20).

Results

The combination of skewness and kurtosis could discriminate the high ICG-R15 (>20) and low (<20) groups (lambda; 0.925, p = 0.025), necro-inflammatory grade (lambda; 0.926, p = 0.026), and fibrosis stage (lambda; 0.752, p < 0.0001) with statistical significance. The difference between the patients with normal values and those with an abnormal platelet count or aspartate transaminase level was also detectable (lambda; 0.901, p < 0.007, and lambda; 0.864, p = 0.001, respectively).

Conclusion

Histogram analyses of the hepatobiliary phase of gadoxetic acid-enhanced MR imaging have potential as a biomarker for the assessment of liver function, liver fibrosis, and necro-inflammation.
Literatur
2.
Zurück zum Zitat Feier D, Balassy C, Bastati N, et al. (2013) Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging. Radiology. 269(2):460–468CrossRefPubMed Feier D, Balassy C, Bastati N, et al. (2013) Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging. Radiology. 269(2):460–468CrossRefPubMed
3.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41(6):1313–1321CrossRefPubMed Kleiner DE, Brunt EM, Van Natta M, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41(6):1313–1321CrossRefPubMed
4.
Zurück zum Zitat Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) Liver biopsy. Hepatology. 49(3):1017–1044CrossRefPubMed Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) Liver biopsy. Hepatology. 49(3):1017–1044CrossRefPubMed
5.
Zurück zum Zitat Takayama Y, Nishie A, Asayama Y, et al. (2015) T1 rho Relaxation of the liver: a potential biomarker of liver function. J Magn Reson Imaging. 42(1):188–195CrossRefPubMed Takayama Y, Nishie A, Asayama Y, et al. (2015) T1 rho Relaxation of the liver: a potential biomarker of liver function. J Magn Reson Imaging. 42(1):188–195CrossRefPubMed
6.
Zurück zum Zitat Elizondo G, Weissleder R, Stark DD, et al. (1990) Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology. 174(3 Pt 1):797–801CrossRefPubMed Elizondo G, Weissleder R, Stark DD, et al. (1990) Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology. 174(3 Pt 1):797–801CrossRefPubMed
7.
Zurück zum Zitat Lucidarme O, Baleston F, Cadi M, et al. (2003) Non-invasive detection of liver fibrosis: is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Eur Radiol. 13(3):467–474PubMed Lucidarme O, Baleston F, Cadi M, et al. (2003) Non-invasive detection of liver fibrosis: is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Eur Radiol. 13(3):467–474PubMed
8.
Zurück zum Zitat Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB (2006) Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology. 239(2):425–437CrossRefPubMed Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB (2006) Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology. 239(2):425–437CrossRefPubMed
9.
Zurück zum Zitat Sevastianova K, Hakkarainen A, Kotronen A, et al. (2010) Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling. Radiology. 256(2):466–473CrossRefPubMed Sevastianova K, Hakkarainen A, Kotronen A, et al. (2010) Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling. Radiology. 256(2):466–473CrossRefPubMed
10.
Zurück zum Zitat Huwart L, Sempoux C, Salameh N, et al. (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 245(2):458–466CrossRefPubMed Huwart L, Sempoux C, Salameh N, et al. (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 245(2):458–466CrossRefPubMed
11.
Zurück zum Zitat Asbach P, Klatt D, Schlosser B, et al. (2010) Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology. 257(1):80–86CrossRefPubMed Asbach P, Klatt D, Schlosser B, et al. (2010) Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology. 257(1):80–86CrossRefPubMed
12.
Zurück zum Zitat Nishie A, Asayama Y, Ishigami K, et al. (2012) MR prediction of liver fibrosis using a liver-specific contrast agent: superparamagnetic iron oxide versus Gd-EOB-DTPA. J Magn Reson Imaging. 36(3):664–671CrossRefPubMed Nishie A, Asayama Y, Ishigami K, et al. (2012) MR prediction of liver fibrosis using a liver-specific contrast agent: superparamagnetic iron oxide versus Gd-EOB-DTPA. J Magn Reson Imaging. 36(3):664–671CrossRefPubMed
13.
Zurück zum Zitat Kim HY, Choi JY, Park CH, et al. (2013) Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis. J Gastroenterol. 48(10):1180–1187CrossRefPubMed Kim HY, Choi JY, Park CH, et al. (2013) Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis. J Gastroenterol. 48(10):1180–1187CrossRefPubMed
14.
Zurück zum Zitat Yamada A, Hara T, Li F, et al. (2011) Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology. 260(3):727–733CrossRefPubMed Yamada A, Hara T, Li F, et al. (2011) Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology. 260(3):727–733CrossRefPubMed
15.
Zurück zum Zitat Kim H, Park SH, Kim EK, et al. (2014) Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement. PLoS One. 9(12):e114224CrossRefPubMedCentral Kim H, Park SH, Kim EK, et al. (2014) Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement. PLoS One. 9(12):e114224CrossRefPubMedCentral
16.
Zurück zum Zitat Kim HY (2013) Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 38(1):52–54CrossRefPubMedPubMedCentral Kim HY (2013) Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 38(1):52–54CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 349(9055):825–832CrossRefPubMed Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 349(9055):825–832CrossRefPubMed
18.
Zurück zum Zitat Kubota K, Makuuchi M, Kusaka K, et al. (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 26(5):1176–1181 Kubota K, Makuuchi M, Kusaka K, et al. (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 26(5):1176–1181
19.
Zurück zum Zitat Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T (1995) Criteria for safe hepatic resection. Am J Surg. 169(6):589–594CrossRefPubMed Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T (1995) Criteria for safe hepatic resection. Am J Surg. 169(6):589–594CrossRefPubMed
20.
Zurück zum Zitat de Graaf W, Hausler S, Heger M, et al. (2011) Transporters involved in the hepatic uptake of (99 m)Tc-mebrofenin and indocyanine green. J Hepatol. 54(4):738–745CrossRefPubMed de Graaf W, Hausler S, Heger M, et al. (2011) Transporters involved in the hepatic uptake of (99 m)Tc-mebrofenin and indocyanine green. J Hepatol. 54(4):738–745CrossRefPubMed
21.
Zurück zum Zitat Huang L, Vore M (2001) Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green. Drug Metab Dispos. 29(5):634–637PubMed Huang L, Vore M (2001) Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green. Drug Metab Dispos. 29(5):634–637PubMed
22.
Zurück zum Zitat Kitao A, Zen Y, Matsui O, et al. (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging-correlation with molecular transporters and histopathologic features. Radiology. 256(3):817–826CrossRefPubMed Kitao A, Zen Y, Matsui O, et al. (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging-correlation with molecular transporters and histopathologic features. Radiology. 256(3):817–826CrossRefPubMed
23.
Zurück zum Zitat Aster RH (1966) Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest. 45(5):645–657CrossRefPubMedPubMedCentral Aster RH (1966) Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest. 45(5):645–657CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kamimoto Y, Horiuchi S, Tanase S, Morino Y (1985) Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology. 5(3):367–375CrossRefPubMed Kamimoto Y, Horiuchi S, Tanase S, Morino Y (1985) Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology. 5(3):367–375CrossRefPubMed
25.
Zurück zum Zitat Okuda M, Li K, Beard MR, et al. (2002) Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 122(2):366–375CrossRefPubMed Okuda M, Li K, Beard MR, et al. (2002) Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 122(2):366–375CrossRefPubMed
26.
Zurück zum Zitat Wai CT, Greenson JK, Fontana RJ, et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 38(2):518–526CrossRefPubMed Wai CT, Greenson JK, Fontana RJ, et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 38(2):518–526CrossRefPubMed
27.
Zurück zum Zitat Haimerl M, Verloh N, Fellner C, et al. (2014) MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 4:5621. Haimerl M, Verloh N, Fellner C, et al. (2014) MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 4:5621.
28.
Zurück zum Zitat Ueno Y, Moriyama M, Uchida T, Arakawa Y (2001) Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease. Hepatology. 33(2):357–362CrossRefPubMed Ueno Y, Moriyama M, Uchida T, Arakawa Y (2001) Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease. Hepatology. 33(2):357–362CrossRefPubMed
29.
Zurück zum Zitat Shibata M, Morizane T, Uchida T, et al. (1998) Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet. 351(9118):1773–1777CrossRefPubMed Shibata M, Morizane T, Uchida T, et al. (1998) Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet. 351(9118):1773–1777CrossRefPubMed
Metadaten
Titel
Histogram analysis of noncancerous liver parenchyma on gadoxetic acid-enhanced MRI: predictive value for liver function and pathology
verfasst von
Yoshiki Asayama
Akihiro Nishie
Kousei Ishigami
Yasuhiro Ushijima
Yukihisa Takayama
Daisuke Okamoto
Nobuhiro Fujita
Tomoharu Yoshizumi
Tomoyuki Hida
Hiroshi Honda
Publikationsdatum
02.05.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 9/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0753-4

Weitere Artikel der Ausgabe 9/2016

Abdominal Radiology 9/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.